Spouting Rock Asset Management, LLC Repligen Corp Transaction History

Spouting Rock Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$162.42 - $220.56 $69,028 - $93,738	-425 Reduced 5.31%	7,572 $1.28 Million
Q3 2022 Nov 08, 2022	SELL	$160.42 - $256.21 $690,126 - $1.1 Million	-4,302 Reduced 34.98%	7,997 $1.5 Million
Q2 2022 Aug 10, 2022	BUY	$140.68 - $188.02 $202,297 - $270,372	1,438 Added 13.24%	12,299 $2 Million
Q1 2022 May 13, 2022	BUY	$161.19 - $257.96 $29,336 - $46,948	182 Added 1.7%	10,861 $2.1 Million
Q4 2021 Feb 10, 2022	SELL	$247.59 - $304.47 $299,583 - $368,408	-1,210 Reduced 10.18%	10,679 $2.83 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $393,435 - $654,904	-2,020 Reduced 14.52%	11,889 $3.44 Million
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $362,260 - $482,554	2,184 Added 18.63%	13,909 $2.78 Million
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $43,288 - $54,302	-240 Reduced 2.01%	11,725 $2.28 Million
Q4 2020 Feb 11, 2021	BUY	$148.08 - $206.57 $1.77 Million - $2.47 Million	11,965 New	11,965 $2.29 Million

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Spouting Rock Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Spouting Rock Asset Management, LLC with notifications on news.